Back
HFA Premium Access

Ivabradine treatment for chronic heart failure in clinical practice is associated with reductions in symptoms and hospitalizations with improved quality of life, independent of beta blocker dose

Session: Poster Session 3 - Drug therapy, other
Topic: Drug therapy, other
Speaker: Professor C. Zugck (Straubing, DE)
Event: HEART FAILURE 2016

Congress Presentation

About the speaker

Professor Christian Zugck

Kardiologische Praxis im Steiner Thor, Straubing (Germany)
0 follower

9 more presentations in this session

Assessment of the use of ESC heart failure guideline recommended therapy among patients followed at a heart failure outpatient clinic participating in the ESC Heart Failure long-term Registry

Speaker: Doctor B. Muk (Budapest, HU)

Access
Abstract
Thumbnail

Long-term follow up of hospitalized patients with systolic heart failure undergoing early treatment with beta-blockers more ivabradine: a randomized study

Speaker: Doctor F. Hidalgo Lesmes (Cordoba, ES)

Access
Abstract
Thumbnail

Comparison of perindopril-amlodipine and losartan-amlodipine combinations in the management of hypertension in patients with metabolic syndrome

Speaker: Doctor J. Uzokov (Tashkent, UZ)

Access
Abstract
Thumbnail

How do we use anticoagulation therapy in the era of novel drugs - results of FIRST II registryy

Speaker: Doctor T. Novakova (Brno, CZ)

Access
Abstract
Thumbnail

Cardioprotective effects of long-term high-dose therapy with atorvastatin in patients with STEMI in the prevention of chronic heart failure

Speaker: Professor V. Oleinikov (Penza, RU)

Access
Abstract
Slides
Thumbnail

Access the full session

Poster Session 3 - Drug therapy, other

Speakers: Professor C. Zugck, Doctor B. Muk, Doctor F. Hidalgo Lesmes, Doctor J. Uzokov, Doctor T. Novakova...
Access
Thumbnail

About the event

Image

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb